PRODUCT
首頁
產品資訊
PRODUCT
首頁
產品資訊
產品特點
| 編號 | 名稱 | 描述 | 純度 |
| HB4003 | Obscurolide A1 | Phosphodiesterase inhibitor. | >98% |
| HB2900 | ODQ | Potent, selective guanylyl cyclase inhibitor | |
| HB0468 | Okadaic Acid | Potent, non-competitive protein phosphatase inhibitor | >98% |
| HB0470 | Okadaic Acid Sodium Salt | Water soluble, potent protein phosphatase 1 and 2A inhibitor | >98% |
| HB1786 | Olanzapine | 5-HT2A and D2 antagonist. Atypical antipsychotic. | >99% |
| HB0472 | Oleyloxyethyl Phosphorylcholine | PLA2 inhibitor | >98% |
| HB4007 | OM173-αA | Farnesyltransferase (FTase) inhibitor | >95% |
| HB1212 | ω-Agatoxin IVA | Potent, selective P-type / Q-type Ca2+ channel blocker | |
| HB1213 | ω-Agatoxin TK | Potent, selective P-type / Q-type Ca2+ channel blocker | |
| HB0473 | Oncrasin 1 | Small molecule RNA polymerase II inhibitor | >98% |
| HB2832 | Ondansetron hydrochloride | Potent, selective 5-HT3 antagonist | >99% |
| HB0474 | Ophiobolin A | Irreversible calmodulin antagonist | >95% |
| HB4009 | Orlistat | Pancreatic, gastric and carboxylester lipase inhibitor | >98% |
| HB1140 | Ouabain | Selective Na+ / K+ ATPase inhibitor | >98% |
| HB1798 | Paliperidone | 5-HT2A and D2 antagonist. Antipsychotic. | >98% |
| HB4013 | Palmarumycin C3 | Rasfarnesyltransferase inhibitor | >97% |
| HB0478 | Paroxetine hydrochloride | Potent, selective serotonin reuptake inhibitor. Selective GRK2 inhibitor. | >99% |
| HB1056 | Paxilline | Potent, reversible, selective KCa channel inhibitor. Also SERCA inhibitor. | >98% |
| HB1393 | PCI 34051 | Potent, selective HDAC8 inhibitor | >98% |
| HB2240 | PD 0325901 | Potent MEK1 and MEK2 inhibitor. Enhances iPSCs generation. | >99% |
| HB4018 | PD 150,606 | Selective, cell permeable calpain inhibitor | >98% |
| HB3584 | PD 173074 | FGFR1/ FGFR3 inhibitor. Inhibits oligodendrocyte progenitor proliferation and differentiation. | >98% |
| HB2244 | PD 98059 | Selective MEK1/MAP2K inhibitor. Enhances ESC self-renewal. | >98% |
| HB2841 | PEAQX (NVP-AAM 077) | Potent, competitive NMDA receptor antagonist | >98% |
| HB4019 | Pellitorine | ACAT (Acyl-CoA cholesteryl acyl transferase) inhibitor. Tingling-inducing agent. | >97% |
| HB4020 | Penicillide | Acyl-CoA-cholesterol acyltransferase (ACAT) inhibitor | >95% |
| HB1057 | Penitrem A | Potent, selective KCa1.1 channel blocker | >98% |
| HB4021 | Pentabromopseudilin | Potent myosin ATPase inhibitor and lipooxygenase inhibitor. | >98% |
| HB3359 | Pepstatin A | Aspartic protease inhibitor | >98% |
| HB1441 | PF 03814735 | Potent Aurora kinase inhibitor | >98% |
| HB1123 | PF 3716556 | Potent, selective acid pump antagonist | >98% |
| HB2170 | PF 670462 | Potent, selective CK1ε and CK1δ inhibitor | >99% |
| HB4024 | Phenylmethylene hydantoin | GSK-3β inhibitor | >97% |
| HB0499 | Philanthotoxin-7,4 | AMPA receptor antagonist | >98% |
| HB0500 | Phloretin | PKC inhibitor | >98% |
| HB1251 | PHT 427 | Akt / PDPK1 inhibitor | >98% |
| HB2503 | PHTPP | Selective ERβ estrogen receptor antagonist | >99% |
| HB2797 | PI 103 hydrochloride | Potent dual PI3-K/mTOR inhibitor | >98% |
| HB0505 | Piceatannol | Syk tyrosine kinase / JAK-1 inhibitor | >98% |
| HB0506 | Picrotoxin | Non-competitive GABAAreceptor antagonist | >98% |
| HB3025 | Pifithrin-μ | p53 inhibitor. Supresses eSC self renewal. | >99% |
| HB4027 | Pikromycin | Prolyl endopeptidase (PREP) inhibitor | >95% |
| HB4028 | Pimprinine | Monoamine oxidase (MAO) inhibitor | >98% |
| HB1474 | PJ-34 | Potent PARP inhibitor | >98% |
| HB0922 | PK 11195 | Peripheral benzodiazepine receptor ligand | >98% |
| HB0508 | PKA inhibitor fragment (6-22) amide | Potent PKA inhibitor | |
| HB0509 | PKA Inhibitor IV | Potent, selective PKA inhibitor | |
| HB0521 | PKC-412 | Broad spectrum protein kinase inhibitor | >96% |
| HB2223 | Pluripotin | Dual ERK1/RasGAP inhibitor. Maintains ESC self-renewal. | >98% |
| HB3573 | PluriSln 1 | SCD1 inhibitor. Selectively eliminates undifferentiated hPSCs from culture. | >99% |
| HB4030 | PLX4720 | Potent and selective cell permeable B-Raf and C-Raf inhibitor | >99% |
| HB1105 | PNU 37883 hydrochloride | Selective vascular KATPchannel antagonist | >99% |
| HB0528 | PNU 74654 | β-catenin inhibitor. Wnt pathway inhibitor. | >99% |
| HB1334 | PP 1 | Potent Src-family tyrosine kinase inhibitor | >99% |
| HB1335 | PP 2 | Potent, selective Src-family tyrosine kinase inhibitor | >99% |
| HB1336 | PP 3 | PP 2 negative control | >98% |
| HB1950 | PPADS tetrasodium salt | Non-selective P2 receptor antagonist | |
| HB2767 | Prazosin hydrochloride | α1 and α2 adrenoceptor antagonist | >99% |
| HB4036 | PS-341 | Highly potent, selective, reversible and cell permeable proteasome inhibitor | >98% |
| HB1148 | Psalmotoxin 1 | Potent, selective ASIC1a blocker | |
| HB4040 | Psicofuranine | Xanthosine monophosphate (XMP) aminase inhibitor | >98% |
| HB0540 | PTP1B Inhibitor | PTP1B inhibitor | >95% |
| HB0539 | PTP Inhibitor IV | PTP inhibitor | >95% |
| HB4044 | Pyripyropene A | Highly specific acyl-coenzyme A cholesterol acetyltransferase 2 inhibitor | >95% |
| HB1395 | Pyroxamide | Potent HDAC inhibitor | >98% |
| HB0541 | QNZ 46 | GluN2C/D selective, non-competitive NMDA receptor antagonist | >98% |
| HB0542 | Quercetin | Enzyme inhibitor | >98% |
| HB0543 | Quercetin Dihydrate | Broad enzyme inhibitor | >95% |
| HB1803 | Quetiapine hemifumarate | 5-HT2 and D2 antagonist. Atypical antipsychotic. | >99% |
| HB4047 | Quinolactacin A | Acetylcholinesterase (AChE) inhibitor | >95% |
| HB4048 | Q-VD-OPh | Cell permeable, irreversible and non-toxic pan-caspase inhibitor | >95% |
| HB1029 | QX 314 bromide | Membrane impermeable Na+ channel blocker | >98% |
| HB1030 | QX 314 chloride | Membrane impermeable Na+ channel blocker | >98% |
| HB2779 | Rapamycin | mTOR inhibitor and potent immunosuppressant | >98% |
| HB1784 | Rasagiline mesylate | Selective, irreversible MAO-B inhibitor | >99% |
| HB1557 | Raseglurant (ADX 10059 hydrochloride) | mGlu5 negative allosteric modulator | >98% |
| HB4052 | Rebeccamycin | Weak topoisomerase I inhibitor. Shows no activity against protein kninases. | >98% |
| HB1106 | Repaglinide | Potent SUR1 / Kir6.2 channel blocker | >99% |
| HB3301 | RepSox | Potent, selective TGF-βRI inhibitor. Enhances cellular reprogramming efficiency | >99% |
| HB1895 | Reserpine | Vesicular monoamine re-uptake blocker | >99% |
| HB4055 | Resveratrol | Potent phenolic antioxidant with many biological actions. COX-1 inhibitor. | >98% |
| HB4057 | Reticulol | Topoisomerase I (Topo I) inhibitor. | >98% |
| HB1377 | RG 108 | Non-nucleoside DNA methyltransferase inhibitor. Enhances iPSC generation efficiency. | >99% |
| HB6093 | Riluzole | Na+ channel blocker / glutamate inhibitor | >98% |
| HB0548 | Riluzole hydrochloride | Na+ channel blocker / glutamate inhibitor | >98% |
| HB1196 | RN 1734 | TRPV4 channel antagonist | |
| HB0554 | Ro 25-6981 maleate | Selective negative allosteric modulator of GluN2B (NR2B) containing NMDARs | >98% |
| HB0560 | Ro-32-0432 | Potent, selective PKC inhibitor | |
| HB4820 | Ro 32-0432 hydrochloride | Potent, selective PKC inhibitor. GRK inhibitor. | >98% |
| HB0556 | Ro 61-8048 | Potent, competitive kynurenine 3-hydroxylase inhibitor | >99% |
| HB4058 | Robotnikinin | Sonic hedgehog (Shh) signaling inhibitor | >97% |
| HB2898 | (R)-(-)-Rolipram | Potent, selective PDE4 inhibitor. Enantiomer of Rolipram | |
| HB2896 | (R,S)-Rolipram | Selective PDE4 inhibitor | >98% |
| HB2897 | (S)-(+)-Rolipram | PDE4 inhibitor. Less potent enantiomer of Rolipram. | |
| HB3706 | (S)-Roscovitine | Potent, selective CDK1 inhibitor | >99% |
| HB0561 | Rottlerin | PKC inhibitor | |
| HB4063 | Rubratoxin A | Potent, selective, competitive PP2A inhibitor | >95% |
| HB4064 | Rubrofusarin | Moderate tyrosinase inhibitor | >98% |
| HB3907 | γ-Rubromycin | Telomerase inhibitor | >98% |
| HB1039 | Rufinamide | Na+ channel blocker | >99% |
| HB1300 | RWJ 67657 | Potent p38 MAPK inhibitor | >98% |
| HB1320 | Ryanodine | Potent Ca2+ release inhibitor | >98% |
| HB4068 | S14161 | pan Class I PI3K isoforms inhibitor | >99% |
| HB0963 | Saclofen | Selective, competitive GABAB receptor antagonist | >99% |
| HB1396 | SAHA | HDAC inhibitor | >98% |
| HB0573 | Salubrinal | Selective elF2α dephosphorylation inhibitor | >99% |
| HB2400 | Salvinorin A | Potent, selective κ opioid receptor (KOP) agonist | |
| HB4076 | Sarcophine | Acetylcholine esterase and ATPase inhibitor | >97% |
| HB1301 | SB 202190 | Potent ATP competitive p38 MAPK inhibitor | >99% |
| HB1302 | SB 203580 | Potent, selective p38 MAPK inhibitor. Stimulates neural stem cell proliferation. | >98% |
| HB1674 | SB 204741 | Potent, selective 5-HT2B receptor antagonist | >99% |
| HB1272 | SB 216763 | Potent, selective cell permeable GSK-3 inhibitor. Promotes mouse ESC pluripotency. | >98% |
| HB1667 | SB 224289 hydrochloride | Selective 5-HT1B receptor antagonist | >95% |
| HB1684 | SB 269970 hydrochloride | Potent, selective 5-HT7 receptor antagonist | >98% |
| HB1764 | SB 271046 hydrochloride | Potent, selective 5-HT6 antagonist | >99% |
| HB3555 | SB 431542 | Potent, selective TGF-βRI ALK5, ALK4, ALK7 inhibitor. Induces sheet formation, proliferation, differentiation of ESC-derived endothelial cells. | >98% |
| HB1252 | SC 66 | Akt inhibitor | >98% |
| HB1643 | SCH 23390 hydrochloride | Potent, selective D1-like receptor antagonist | >98% |
| HB1124 | SCH 28080 | Potent, competitive gastric K+ / H+ -ATPase inhibitor | >99% |
| HB4080 | Sclerotiorin | Potent aldose reductase inhibitor | >97% |
| HB1398 | Scriptaid | Potent HDAC inhibitor | >99% |
| HB0580 | SDZ 220-581 | Competitive NMDA receptor antagonist | >98% |
| HB4296 | Sephin1 | Selective PP1R15A inhibitor | >95% |
| HB4081 | Sericic acid | Phosphodiesterase 4 (PDE4) inhibitor with various biological actions | >95% |
| HB1717 | Sertraline hydrochloride | Potent, selective 5-HT re-uptake inhibitor (SSRI) | >99% |
| HB1713 | Sibutramine hydrochloride | 5-HT and norepinephrine re-uptake inhibitor (SNRI) | >99% |
| HB4084 | Simocyclinone D8 | Bacterial DNA gyrase inhibitor | >97% |
| HB0583 | S-Isopropyl-ITU hydrobromide | Potent, competitive NOS inhibitor | |
| HB0976 | SKF 89976A hydrochloride | Potent, selective, competitive GAT-1 GABA uptake inhibitor | >99% |
| HB4088 | Skyrin | Selective glucagon receptor antagonist. Non-peptidic anti-diabetic agent | >97% |
| HB0584 | SL 0101-1 | Selective p90 ribosomal S6 kinase inhibitor | >95% |
| HB1350 | SL327 | Selective MEK1 and MEK2 inhibitor | >98% |
| HB1235 | SNX 482 | Potent, selective Cav2.3 (R-type) channel blocker | |
| HB1399 | Sodium butyrate | HDAC inhibitor. Directs mESC differentiation into hepatocytes. | |
| HB0290 | Sodium Fluoride | Serine/threonine phosphatase inhibitor | >99% |
| HB2234 | SP600125 | Selective, ATP-competitive JNK inhibitor. Prevents BMP9-induced osteogenic MSC differentiation. | >98% |
| HB2799 | Spironolactone | Mineralocorticoid and androgen receptor antagonist | >98% |
| HB4091 | Splitomicin | Potent,selective, cell permeable yeast NAD+-dependent HDAC Sir2p inhibitor | >98% |
| HB2296 | SR 3677 dihydrochloride | Potent, selective ROCK inhibitor | >98% |
| HB0901 | SR 95531 hydrobromide (Gabazine) | Selective, competitive GABAA receptor antagonist | >98% |
| HB1437 | Stattic | Selective STAT3 inhibitor | >99% |
| HB3011 | Stauprimide | NME2 nuclear translocation inhibitor. Primes ESCs for differentiation. | >98% |
| HB0590 | Staurosporine | Potent, non-specific protein kinase inhibitor | >99% |
| HB0591 | Stearoyl Carnitine | PKC inhibitor | |
| HB4095 | Stigmasterol | Phytosterol with anticancer and many other biological actions. Farnesoid X receptor antagonist. | >95% |
| HB0593 | STO-609 acetate | Potent, competitive, selective CaM-KK inhibitor | >98% |
| HB4096 | Streptochlorin | TNFα-induced NF-κB activation inhibitor. | >95% |
| HB3133 | SU 5402 | Potent FGFR and VEGFR inhibitor. Attenuates integrin β4-induced neural stem cell differentiation. | >95% |
| HB1835 | (RS)-(±)-Sulpiride | Standard D2-like dopamine receptor antagonist | >98% |
| HB4100 | Swinholide A | Actin filament inhibitor. Disrupts actin cytoskeleton. | >97% |
| HB0599 | TAK 715 | Potent, p-38 MAP kinase inhibitor. Wnt/β-catenin signaling inhibitor. | >99% |
| HB0601 | Tamoxifen | Estrogen receptor antagonist/ partial agonist | >99% |
| HB0602 | Tamoxifen Citrate | Estrogen receptor antagonist/ partial agonist | >99% |
| HB0603 | Tautomycin | Potent, selective PP1 / PP2A inhibitor | >90% |
| HB0258 | DL-TBOA | Competitive EAAT blocker. Inhibits glutamate uptake. | >98% |
| HB1400 | TC-H 106 | Selective class I HDAC inhibitor | >99% |
| HB1033 | TC-N 1752 | Potent, selective Nav1.7 inhibitor | >99% |
| HB0604 | TCN 201 | Potent, non-competitive GluN2A subunit selective NMDA receptor antagonist | >99% |
| HB1800 | Tegaserod maleate | 5-HT4 partial agonist | >99% |
| HB4101 | Terpendole C | Acyl-CoA cholesterol acyltransferase 1 and 2 inhibitor | >95% |
| HB4104 | Territrem B | Potent, specific, irreversible acetylcholinesterase (AChE) inhibitor. | >95% |
| HB1711 | Tetrabenazine | Potent inhibitor of vesicular monoamine transport; depletes 5-HT stores | >98% |
| HB1088 | Tetraethylammonium chloride (TEA) | Non-selective K+ channel blocker | |
| HB1034 | Tetrodotoxin (citrate free) | Potent, selective, use-dependent Na+ channel blocker. Citrate free. | >99% |
| HB1035 | Tetrodotoxin citrate | Potent, selective, use-dependent Na+ channel blocker. Citrate Salt. | >99% |
| HB1118 | Thapsigargin | Potent, non-competitive SERCA inhibitor | >97% |
| HB2849 | Theophylline | Adenosine receptor antagonist | |
| HB3240 | Thiazovivin | Rock inhibitor. Improves fibroblast reprogramming efficiency and iPSCs induction. | >97% |
| HB0388 | L-threo-Sphingosine C-18 | PKC inhibitor | >98% |
| HB0978 | Tiagabine hydrochloride | Selective GAT-1 GABA uptake inhibitor | >99% |
| HB0618 | Topiramate | Selective GluK1 kainate receptor antagonist | >99% |
| HB0879 | Torcetrapib | Cholesteryl ester transfer protein inhibitor | >99% |
| HB2253 | Torin 1 | Potent, selective mTOR inhibitor | >98% |
| HB2254 | Torin 2 | Potent, selective mTOR inhibitor | >98% |
| HB4111 | TPh A | Nuclear protein pirin inhibitor | >98% |
| HB1058 | TRAM 34 | Potent, selective KCa3.1 channel blocker | >99% |
| HB1201 | Tranilast | TRPV2 channel inhibitor. Potent mast cell stabilizer. | >99% |
| HB1412 | Tranylcypromine hydrochloride | LSD1 / MAO inhibitor. Enables reprogramming of mouse embryonic fibroblasts into iPS cells. | >98% |
| HB1402 | Trichostatin A | Potent HDAC inhibitor. Induces hiPSCs differentiation to cardiogenic cells. | >98% |
| HB4112 | Tripolin A | Non-ATP competitive Aurora A and B kinase inhibitor | >98% |
| HB4113 | Tripolin B | Specific, non-ATP competitive Aurora A inhibitor | >98% |
| HB2827 | Tropisetron hydrochloride | Potent 5-HT3 receptor antagonist. Also α7 nAChR partial agonist. | >99% |
| HB1403 | Tubacin | Selective HDAC6 inhibitor | >98% |
| HB0880 | Tunicamycin | GlcNAc phosphotransferase inhibitor | |
| HB0622 | TX-1123 | Tyrosine kinase inhibitor | |
| HB2246 | U0126 | Potent, selective MEK-1/MEK-2 inhibitor | >99% |
| HB3334 | U 18666A | Hedgehog signaling inhibitor. Also cholesterol synthesis inhibitor. | |
| HB0628 | UBP 310 | Potent, selective GluK1 / GluK3 subunit selective kainate receptor antagonist | >98% |
| HB0630 | UCPH 101 | UCPH-101 is a potent, selective, non-competitive EAAT1 inhibitor | >98% |
| HB6130 | UCPH-102 | Selective EAAT1 inhibitor | >98% |
| HB4117 | UK-1 | Topoisomerase II inhibitor | >98% |
| HB1420 | UNC 0224 | Potent, selective G9a HMTase inhibitor | >98% |
| HB1423 | UNC 0646 | Potent, selective G9a / GLP HMTase inhibitor | >99% |
| HB1693 | Urapidil hydrochloride | Selective 5-HT1A agonist. α1-adrenoceptor antagonist | >99% |
| HB0867 | Valproic acid sodium salt | Histone deacetylase inhibitor. Shows multitude of biological actions. Enables pluripotent stem cell induction from somatic cells. | |
| HB1743 | Venlafaxine hydrochloride | Serotonin/norepinephrine re-uptake inhibitor | >99% |
| HB1237 | Verapamil hydrochloride | L-type Ca2+ channel blocker | >99% |